Company Overview
Accenture plc provides strategy and consulting, industry X, song, and technology and operation services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers systems integration and application management; security; intelligent platform; infrastructure; software engineering; data, AI, cloud; and automation and global delivery services. The company also operates business processes for specific enterprise functions, including finance and accounting, sourcing and procurement, supply chain, marketing and sales, and human resources, as well as industry-specific services, such as platform trust and safety, banking, insurance, network and health services; and designs, manufactures, and assembles automation equipment, robotics, and other commercial hardware products. It serves communications, media, and technology; financial services; banking and capital markets, and insurance; health and public service; consumer goods, retail, travel services; industrial; life science; and chemicals, natural resources, energy, and utilities sectors. Accenture plc has collaboration with Amazon Web Services (AWS) to deliver transformative digital services to public sector, defense, and national security organizations. It has a collaboration with OpenAI to help enterprise clients unlock new levels of innovation and growth by bringing agentic AI systems; and has a strategic collaboration with Microsoft and Avanade for the development of an agentic factory intelligence system. It also has strategic partnership with Netomi, Inc. to help enterprises reinvent customer experience using agentic AI systems. Accenture plc was founded in 1951 and is based in Dublin, Ireland.
Why Investors Should Care
Generates a return on equity of 24.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 23.3%.
Trades at a P/E of 11.2, below the sector median of 34.7.
Carries low leverage with a debt-to-equity ratio of 0.25.
Offers a dividend yield of 3.83%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Aug 2025 Revenue of $69.67B (+7.4% YoY); net profit $7.68B.
- Trailing 12 Months Year-on-year growth — revenue +8.3%, earnings +4.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.2%, profit CAGR 3.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 4.19% |
| 1 Year: | 8.30% |
Compounded Profit Growth
| 5 Years: | 3.74% |
| 1 Year: | 4.00% |
Stock Price Performance
| 1 Year: | -50.05% |
| 6 Months: | -50.23% |
| 3 Months: | -27.16% |
| 1 Month: | -18.56% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.02 · Neutral
P/E of 11.24 is below the sector median of 34.66 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 24.8%.
- Healthy ROCE of 23.3%.
- Attractive dividend yield of 3.83%.
- Generates positive free cash flow.
CONS
- Trading 51.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACN Accenture plc SPX | 137.02 | 11.24 | $84.12B | 3.83% | 23.31% | 24.76% | 4.19% | 3.74% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 212.50 | 32.59 | $5.15T | 0.47% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 327.50 | 39.60 | $4.81T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 395.63 | 23.96 | $2.94T | 0.95% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 419.48 | 36.41 | $2.18T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 394.28 | 64.96 | $1.88T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 904.28 | 20.44 | $1.02T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 529.14 | 172.36 | $862.82B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,815.27 | 59.79 | $699.64B | 0.51% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | May 2016 | Aug 2016 | Nov 2016 | Feb 2017 | May 2017 | Aug 2017 | Nov 2017 | Feb 2018 | May 2018 | Aug 2018 | Nov 2018 | Feb 2019 | May 2019 | Aug 2019 | Nov 2019 | Feb 2020 | May 2020 | Aug 2020 | Nov 2020 | Feb 2021 | May 2021 | Aug 2021 | Nov 2021 | Feb 2022 | May 2022 | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.97B | 8.97B | 9.01B | 8.76B | 9.36B | 9.64B | 9.88B | 9.91B | 10.69B | 10.50B | 10.61B | 10.45B | 11.10B | 11.06B | 11.36B | 11.14B | 10.99B | 10.84B | 11.76B | 12.09B | 13.26B | 13.42B | 14.97B | 15.05B | 16.16B | 15.42B | 15.75B | 15.81B | 16.56B | 15.99B | 16.22B | 15.80B | 16.47B | 16.41B | 17.69B | 16.66B | 17.73B | 17.60B | 18.74B | 18.04B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.68B | 11.90B | 11.99B | 12.55B | 12.58B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.97B | 5.83B | 5.61B | 6.20B | 5.46B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.73B | 2.84B | 2.95B | 3.02B | 2.97B |
| Operating Income | 1.31B | 1.20B | 1.33B | 1.14B | 865.43M | 1.30B | 1.50B | 1.30B | 1.63B | 1.47B | 1.63B | 1.39B | 1.72B | 1.57B | 1.77B | 1.49B | 1.71B | 1.54B | 1.89B | 1.65B | 2.12B | 1.96B | 2.43B | 2.06B | 2.60B | 2.27B | 2.59B | 1.94B | 2.36B | 1.91B | 2.56B | 2.05B | 2.63B | 2.35B | 2.95B | 2.24B | 2.98B | 2.67B | 3.18B | 2.49B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.71B | 3.31B | 2.64B | 3.33B | 2.83B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 64.67M | 67.60M | 66.24M | 65.36M | 63.57M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.29B | 2.95B | 2.08B | 2.97B | 2.46B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 466.33M | 707.18M | 625.43M | 725.77M | 597.27M |
| Net Income | 897.25M | 1.07B | 1.00B | 838.75M | 669.47M | 932.45M | 1.12B | 863.70M | 1.04B | 1.03B | 1.27B | 1.12B | 1.25B | 1.13B | 1.36B | 1.23B | 1.23B | 1.29B | 1.50B | 1.44B | 1.55B | 1.42B | 1.79B | 1.63B | 1.79B | 1.67B | 1.96B | 1.52B | 2.01B | 1.37B | 1.97B | 1.67B | 1.93B | 1.68B | 2.28B | 1.79B | 2.20B | 1.41B | 2.21B | 1.83B |
| Diluted EPS | 1.41 | 1.68 | 1.58 | 1.33 | 1.05 | 1.48 | 1.79 | 1.37 | 1.60 | 1.58 | 1.96 | 1.73 | 1.93 | 1.74 | 2.09 | 1.91 | 1.90 | 1.99 | 2.32 | 2.23 | 2.40 | 2.20 | 2.78 | 2.54 | 2.79 | 2.60 | 3.08 | 2.39 | 3.15 | 2.15 | 3.10 | 2.63 | 3.04 | 2.66 | 3.59 | 2.82 | 3.49 | 2.25 | 3.54 | 2.93 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Aug 2011 | Aug 2012 | Aug 2013 | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.31B | 23.17B | 23.09B | 27.35B | 29.78B | 30.39B | 31.87B | 32.91B | 34.80B | 36.18B | 40.99B | 43.22B | 44.33B | - | 61.59B | 64.11B | 64.90B | 69.67B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 41.89B | 43.38B | 43.73B | 47.44B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.70B | 20.73B | 21.16B | 22.24B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.33B | 10.86B | 11.13B | 11.39B |
| Operating Income | 3.01B | 2.64B | 2.91B | 3.47B | 3.87B | 4.34B | 4.30B | 4.44B | 4.81B | 5.19B | 5.90B | 6.31B | 6.51B | - | 9.37B | 9.87B | 10.03B | 10.84B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.27B | 10.25B | 10.84B | 11.87B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 47.32M | 47.52M | 58.97M | 228.56M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.20B | 9.14B | 9.70B | 10.27B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.21B | 2.14B | 2.28B | 2.44B |
| Net Income | 1.69B | 1.59B | 1.78B | 2.28B | 2.55B | 3.28B | 2.94B | 3.05B | 4.11B | 3.45B | 4.06B | 4.78B | 5.11B | - | 6.88B | 6.87B | 7.26B | 7.68B |
| Diluted EPS | 2.64 | 2.44 | 2.66 | 3.39 | 3.84 | 4.93 | 4.52 | 4.76 | 6.45 | 5.44 | 6.34 | 7.36 | 7.89 | - | 10.71 | 10.77 | 11.44 | 12.15 |
| R&D Expense | 390.17M | 434.94M | 376.99M | 481.97M | 559.61M | 715.09M | 639.51M | 625.54M | 643.41M | 704.32M | 790.78M | 799.73M | 870.61M | 1.12B | 1.12B | 1.30B | 1.15B | 817.30M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Aug 2007 | Aug 2008 | Aug 2009 | Aug 2010 | Aug 2011 | Aug 2012 | Aug 2013 | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 12.26B | 12.84B | 15.73B | 16.67B | 16.87B | 17.93B | 18.20B | 20.61B | 22.69B | 24.45B | 29.79B | 37.08B | - | 47.26B | 51.25B | 55.93B | 65.39B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.61B | 23.38B | 20.86B | 28.90B |
| Cash & Equivalents | 3.31B | 3.60B | 4.54B | 4.84B | 5.70B | 6.64B | 5.63B | 4.92B | 4.36B | 4.91B | 4.13B | 5.06B | 6.13B | 8.42B | - | 7.89B | 9.05B | 5.00B | 11.48B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.48B | 10.69B | 11.87B | 13.07B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 24.52B | 24.79B | 26.76B | 33.15B |
| Current Liabilities | - | - | 6.24B | 6.57B | 7.91B | 8.11B | 8.16B | 8.16B | 8.49B | 8.88B | 9.82B | 10.15B | 11.06B | 12.66B | - | 17.52B | 18.01B | 18.98B | 20.35B |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.89M | 43.09M | 78.63M | 5.03B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.33B | 3.15B | 4.12B | 8.18B |
| Total Equity | 2.64B | 3.02B | 2.84B | 2.84B | 3.88B | 4.15B | 4.96B | 5.73B | 6.13B | 7.56B | 8.95B | 10.36B | 14.41B | 17.00B | - | 22.11B | 25.69B | 28.29B | 31.20B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 664.56M | 664.62M | 672.48M | 657.96M |
Cash Flows (Annual)
Figures in USD.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Aug 2011 | Aug 2012 | Aug 2013 | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.80B | 3.16B | 3.09B | 3.44B | 4.26B | 3.30B | 3.49B | 4.18B | 4.67B | 4.97B | 6.03B | 6.63B | 8.22B | - | 9.54B | 9.52B | 9.13B | 11.47B |
| Investing Cash Flow | -323.99M | -245.17M | -273.76M | -703.39M | -535.38M | -1.16B | -1.06B | -1.17B | -610.35M | -2.23B | -1.25B | -1.76B | -1.89B | - | -4.26B | -2.62B | -7.06B | -2.02B |
| Financing Cash Flow | -2.16B | -1.85B | -2.43B | -2.12B | -2.56B | -3.07B | -3.17B | -3.29B | -3.49B | -3.56B | -3.71B | -3.77B | -4.05B | - | -5.31B | -5.65B | -6.06B | -2.95B |
| Capital Expenditure | -320.37M | -243.46M | -238.22M | -403.71M | -371.97M | -369.59M | -321.87M | -395.02M | -496.57M | -515.92M | -619.19M | -599.01M | -599.13M | - | -718.00M | -528.17M | -516.51M | -600.04M |
| Free Cash Flow | 2.48B | 2.92B | 2.85B | 3.04B | 3.88B | 2.93B | 3.16B | 3.78B | 4.17B | 4.46B | 5.41B | 6.03B | 7.62B | - | 8.82B | 9.00B | 8.61B | 10.87B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -30.53M | 1.26B | -3.99B | 6.51B |
| Share Buybacks | 2.26B | 1.86B | 2.07B | 2.17B | 2.10B | 2.54B | 2.56B | 2.45B | 2.60B | 2.65B | 2.64B | 2.69B | 2.92B | 3.70B | 4.12B | 4.33B | 4.52B | 4.62B |
Ratios (Annual)
Figures in %.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Aug 2011 | Aug 2012 | Aug 2013 | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.0% | 32.3% | 32.6% | 31.9% |
| Operating Margin % | 11.9% | 11.4% | 12.6% | 12.7% | 13.0% | 14.3% | 13.5% | 13.5% | 13.8% | 14.4% | 14.4% | 14.6% | 14.7% | - | 15.2% | 15.4% | 15.5% | 15.6% |
| Net Margin % | 6.7% | 6.9% | 7.7% | 8.3% | 8.6% | 10.8% | 9.2% | 9.3% | 11.8% | 9.5% | 9.9% | 11.1% | 11.5% | - | 11.2% | 10.7% | 11.2% | 11.0% |
| ROE % | 56.0% | 56.1% | 62.8% | 58.7% | 61.6% | 66.2% | 51.3% | 49.8% | 54.4% | 38.5% | 39.2% | 33.2% | 30.0% | - | 31.1% | 26.7% | 25.7% | 24.6% |
| ROCE % | - | 43.9% | 46.5% | 44.4% | 45.2% | 49.8% | 44.0% | 45.7% | 41.0% | 40.4% | 41.3% | 33.7% | 26.7% | - | 31.5% | 29.7% | 27.2% | 24.1% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ACN
What’s Next for IBM Stock After 25% Collapse
Shares in the IT company aren’t mounting a comeback as investors reel from Tuesday’s brutal selloff.
IBM Just Crashed. If Wall Street Pros Are Right The Stock Could Soar From Here
IBM just suffered its worst single-day collapse since 1968, wiping out two years of gains in one brutal session. Wall Street analysts refuse to budge on their targets, creating one of the widest price dislocations in large-cap tech and a hi…
IBM Stock's Sudden Reversal: From 'Buy Now' to Under Investigation
Just one day after glowing reviews, a surprise revenue warning sent the stock into a tailspin and brought lawyers to the door.
Accenture (ACN) Signs Multi-Million Euro Contract With the NATO Communications and Information Agency
Accenture plc (NYSE:ACN) is one of the top cheap blue chip stocks to buy according to Wall Street analysts. Accenture plc (NYSE:ACN) announced on July 7 the signing of a multi-million euro contract with the NATO Communications and Informati…
Stock Market Today, July 14: IBM Plunges on Second-Quarter Warning as AI Shifts Enterprise Spending
Today, July 14, 2026, customers redirected IT budgets away from software and infrastructure, raising questions about near-term demand durability.
IonQ and 3 More Stocks That Together Make a Better IBM
HSBC downgrades IBM shares to the equivalent of Sell, pointing to better investment opportunities in a basket of stocks including IonQ and Accenture.
ACN — Frequently Asked Questions
What is the current share price of Accenture plc (ACN)?
As of 2026-07-15 16:51 PDT, Accenture plc (ACN) trades at $137.02 on NYSE. Its 52-week range is $122.96 to $282.71.
What is the market capitalisation of ACN?
Accenture plc (ACN) has a market capitalisation of $84.12B on NYSE.
What is the P/E ratio of ACN?
ACN trades at a trailing price-to-earnings (P/E) ratio of 11.24. The industry average P/E is 34.66. Its price-to-book (P/B) ratio is 3.35.
Does ACN pay a dividend?
Accenture plc (ACN) currently offers a dividend yield of 3.83%.
What is the return on equity (ROE) of ACN?
ACN has a return on equity (ROE) of 24.76%. Its return on capital employed (ROCE) is 23.31%.
Is ACN a good stock to buy?
This page provides a data-driven analysis of Accenture plc (ACN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.